Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Artículo en Inglés | MEDLINE | ID: mdl-38763779

RESUMEN

On 2 May 2023, the Australian Federal Government announced a suite of reforms aimed at ensuring the effectiveness of the prescription model of regulation of vaping (or e-cigarette) products in Australia. These reforms are intended to protect Australians, particularly young people, from the harms of vaping and nicotine dependence. The ensuing public debate on the issue has often created the impression that the options under consideration are to either retain 'recently introduced' prescription regulation or to 'revert to' a retail supply approach. However, the sale of nicotine vapes by retailers such as tobacconists and convenience stores has never been lawful in Australia. The reforms do not seek to change the way nicotine vaping products are regulated, but rather to ensure that the existing prescription model can be effectively enforced and can function as originally intended. This paper describes the historical context and rationale for strengthening prescription regulation of vapes in this country.

2.
Aust N Z J Public Health ; 48(2): 100142, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38574430

RESUMEN

OBJECTIVE: We aimed to evaluate Aboriginal and Torres Strait Islander involvement in research focusing on cancer experiences using an Aboriginal and Torres Strait Islander quality appraisal tool (the QAT). METHODS: We conducted a systematic review of the peer-reviewed literature on Aboriginal and Torres Strait Islander peoples' experiences associated with cancer, recently published elsewhere. We then appraised articles for the inclusion of Aboriginal and Torres Strait Islander-led research, community consultation, and involvement. RESULTS: 91 articles were appraised. A lack of Aboriginal and Torres Strait Islander-led research and consultation was reported in the majority of articles, only 10 (11%) demonstrated success across seven (50%) or more questions of the QAT. CONCLUSIONS: This review underscores the need for anti-racist research and publication practices that actively engage Aboriginal and Torres Strait Islander peoples and researchers. This approach is vital to enhance cancer outcomes within these communities. IMPLICATIONS FOR PUBLIC HEALTH: To advance and prioritise appropriate involvement of Aboriginal and Torres Strait Islander peoples in cancer research, the onus must be on 'systems owners,' including academic journals and institutions, to require and report genuine engagement as standard practice. Researchers will produce higher-calibre research with a strengths-based focus, advancing the cause of equitable research.


Asunto(s)
Servicios de Salud del Indígena , Nativos de Hawái y Otras Islas del Pacífico , Neoplasias , Humanos , Neoplasias/etnología , Australia , Investigación Biomédica , Aborigenas Australianos e Isleños del Estrecho de Torres
3.
BMC Public Health ; 24(1): 523, 2024 Feb 20.
Artículo en Inglés | MEDLINE | ID: mdl-38378574

RESUMEN

BACKGROUND: Persistent disparities exist between Aboriginal and Torres Strait Islander peoples (the Indigenous peoples of Australia) and non-Indigenous Australians associated with cancer, with Aboriginal and Torres Strait Islander peoples experiencing a longer time to treatment, higher morbidity rates, and higher mortality rates. This systematic review aimed to investigate findings and recommendations in the literature about the experiences and supportive care needs of Aboriginal and Torres Strait Islander peoples with cancer in Australia. METHODS: A qualitative systematic review was conducted using thematic analysis. Database searches were conducted in CINAHL, Informit, MEDLINE, ProQuest, Scopus, and Web of Science for articles published between January 2000 and December 2021. There were 91 included studies which were appraised using the Mixed Methods Appraisal Tool. The included studies reported on the experiences of cancer and supportive care needs in Aboriginal and Torres Strait Islander populations. RESULTS: Six key themes were determined: Culture, family, and community; cancer outcomes; psychological distress; access to health care; cancer education and awareness; and lack of appropriate data. Culture was seen as a potential facilitator to achieving optimal cancer care, with included studies highlighting the need for culturally safe cancer services and the routine collection of Aboriginal and Torres Strait Islander status in healthcare settings. CONCLUSION: Future work should capitalize on these findings by encouraging the integration of culture in healthcare settings to increase treatment completion and provide a positive experience for Aboriginal and Torres Strait Islander peoples with cancer.


Asunto(s)
Aborigenas Australianos e Isleños del Estrecho de Torres , Servicios de Salud del Indígena , Neoplasias , Humanos , Australia/epidemiología , Atención a la Salud , Neoplasias/terapia
8.
Addict Behav ; 112: 106575, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-32871404

RESUMEN

BACKGROUND: The hardening hypothesis proposes that as smoking rates decline, the remaining smokers will become hardcore and resistant to quitting. This group of highly resistant quitters will potentially require more individualistic approaches to cessation and harm reduction. The harm reduction approach (specifically e-cigarettes) has been proposed as an option to address hardened Australian smokers. We tested the hardening hypothesis by analysing the rates of hardcore smoking in the Australian smoking population between 2010 and 2016. METHODS: Data were drawn from three waves of the National Drug Strategy Household Survey (NDSHS) in 2010, 2013 and 2016. Two different definitions were used to assess hardcore smoking to arrive at an upper and lower rate. Logistic regression models assessed hardcore smoker characteristics for both definitions of hardcore smoking. RESULTS: The most inclusive definition of hardcore smoking (i.e., a smoker with no plan to quit) showed a significant decline in hardcore smoking between 2010 and 2016 (5.49%-4.85%) In contrast, the prevalence of hardcore smoking using the most stringent definition (i.e., a current daily smoker of at least 15 cigarettes per day, aged 26 years or over, with no intention to quit, a lifetime consumption of at least 100 cigarettes, and no quit attempt in the past 12 months) did not change significantly between 2010 and 2016. CONCLUSION: The observed trends in the prevalence of hardcore smokers (i.e., either stable or declining depending on the definition) suggest that the Australian smoking population is not hardening. These results do not support claims that remaining smokers are becoming hardcore.


Asunto(s)
Sistemas Electrónicos de Liberación de Nicotina , Cese del Hábito de Fumar , Productos de Tabaco , Adulto , Australia/epidemiología , Humanos , Fumar/epidemiología
9.
Respirology ; 25(10): 1082-1089, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32713105

RESUMEN

The TSANZ develops position statements where insufficient data exist to write formal clinical guidelines. In 2018, the TSANZ addressed the question of potential benefits and health impacts of electronic cigarettes (EC). The working party included groups focused on health impacts, smoking cessation, youth issues and priority populations. The 2018 report on the Public Health Consequences of E-Cigarettes from the United States NASEM was accepted as reflective of evidence to mid-2017. A search for papers subsequently published in peer-reviewed journals was conducted in August 2018. A small number of robust and important papers published until March 2019 were also identified and included. Groups identified studies that extended, modified or contradicted the NASEM report. A total of 3793 papers were identified and reviewed, with summaries and draft position statements developed and presented to TSANZ membership in April 2019. After feedback from members and external reviewers, a collection of position statements was finalized in December 2019. EC have adverse lung effects and harmful effects of long-term use are unknown. EC are unsuitable consumer products for recreational use, part-substitution for smoking or long-term exclusive use by former smokers. Smokers who require support to quit smoking should be directed towards approved medication in conjunction with behavioural support as having the strongest evidence for efficacy and safety. No specific EC product can be recommended as effective and safe for smoking cessation. Smoking cessation claims in relation to EC should be assessed by established regulators.


Asunto(s)
Sistemas Electrónicos de Liberación de Nicotina , Sociedades Médicas , Adolescente , Adulto , Australia , Femenino , Humanos , Masculino , Nueva Zelanda , Salud Pública , Factores de Riesgo , Fumar/efectos adversos , Cese del Hábito de Fumar , Fumar Tabaco , Estados Unidos
10.
J Public Health Policy ; 41(3): 286-302, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-32366990

RESUMEN

We undertook a systematic review to identify and summarise studies on hardcore smoking and hardening to: determine the degree of variability in definitions of hardcore smoking and hardening; assess the evidence for claims that smokers are becoming increasingly hardened within the context of harm reduction as a policy initiative; and identify the determining characteristics of a hardcore smoker. We searched five electronic databases from 1970 to mid-April 2018 using the search term "smok* AND hard* AND (tobacco OR cigar* OR nicotin*)". We included studies if they included a definition of hardcore smokers and/or hardening, and provided a prevalence rate for hard core smokers or empirical evidence for hardening. Definitions of hardcore smoker varied substantially across studies. Hardening was not evident in the general smoking population and we found mounting evidence of softening occurring in smoking populations. These results indicate that hardening of smokers is not occurring and that calls for policy interventions on this basis should be challenged.


Asunto(s)
Reducción del Daño , Fumadores/estadística & datos numéricos , Cese del Hábito de Fumar/métodos , Fumar/epidemiología , Adulto , Anciano , Sistemas Electrónicos de Liberación de Nicotina , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Fumadores/psicología , Fumar/psicología , Cese del Hábito de Fumar/psicología , Factores Socioeconómicos , Productos de Tabaco/provisión & distribución , Dispositivos para Dejar de Fumar Tabaco/provisión & distribución
11.
Public Health Res Pract ; 30(3)2020 Sep 09.
Artículo en Inglés | MEDLINE | ID: mdl-36823799

RESUMEN

OBJECTIVES: Smoke-free environments have been one of the great success stories in tobacco control in Australia. In this paper, we describe the current situation with respect to smoke-free environments in Australia, identify opportunities for extending and/or strengthening smoke-free environments, and discuss the challenges alternative nicotine delivery devices such as e-cigarettes pose to the traditional notion of 'smoke-free'. Type of program: Smoke-free environments are an essential element in a comprehensive approach to tobacco control. They are recognised in the World Health Organization Framework Convention on Tobacco Control and in the Australian National Tobacco Strategy. RESULTS: There is strong evidence that smoke-free environments support smokers to make a quit attempt, support ex-smokers to maintain their resolve, and protect the health of non-smokers and ex-smokers alike. LESSONS LEARNT: Smoke-free environments have contributed to reductions in smoking prevalence. They are not yet fully deployed in public policy in Australia, and policy makers should extend smoke-free environments to areas such as high-roller rooms in casinos, prisons, residential mental health facilities and multi-unit residences. E-cigarettes are challenging the ways we think about 'smoke-free', and have the capacity to undermine smoke-free successes if regulation does not prevent their use in smoke-free environments.

12.
Trop Med Infect Dis ; 3(3)2018 Aug 21.
Artículo en Inglés | MEDLINE | ID: mdl-30274486

RESUMEN

Venomous snake bites in the Solomon Islands can be very dangerous due to lack of access to health care. There are no documented case reports of envenomation by snake bites in the Solomon Islands. This case report highlights the management of a patient with potentially lethal neurotoxicity secondary to a Solomonelaps par (Solomons coral snake) in a low resource setting. This case identifies the potential benefit of further research to determine the incidence of lethal envenomation as well as analysing the venom to determine if any commercially available antivenom would be useful in the treatment of envenomation by Salomonelaps par and other venomous snakes. There should be consideration given to providing education on first aid for people living in remote areas as well as education for health workers.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...